Asahi Kasei Corporation
- Home
- Companies
- Asahi Kasei Corporation
- Products
- RECLAST - Zoledronic Acid
RECLAST - Zoledronic Acid
Reclast® is a bisphosphonate agent that suppresses bone resorption, for the treatment of osteoporosis. Reclast® is capable of a year-long treatment with once-a-year intravenous infusion. Reclast® is a registered trademark of Novartis.
Most popular related searches
